Reflect Scientific, Inc.
RSCF
$0.04
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 514.00K | 590.10K | 428.80K | 188.80K | 525.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 514.00K | 590.10K | 428.80K | 188.80K | 525.90K |
| Cost of Revenue | 186.20K | 231.50K | 187.00K | 110.40K | 195.90K |
| Gross Profit | 327.80K | 358.60K | 241.80K | 78.40K | 330.00K |
| SG&A Expenses | 225.50K | 255.60K | 274.90K | 289.00K | 240.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 414.80K | 491.70K | 469.30K | 408.30K | 445.00K |
| Operating Income | 99.20K | 98.30K | -40.50K | -219.60K | 80.90K |
| Income Before Tax | 110.00K | 109.00K | -32.00K | -216.40K | 86.30K |
| Income Tax Expenses | 100.00 | -- | -- | 0.00 | -- |
| Earnings from Continuing Operations | 109.90K | 109.00K | -32.00K | -216.40K | 86.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.90K | 109.00K | -32.00K | -216.40K | 86.30K |
| EBIT | 99.20K | 98.30K | -40.50K | -219.60K | 80.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 85.66M | 85.66M | 85.66M | 85.23M | 85.21M |
| Average Diluted Shares Outstanding | 85.66M | 85.66M | 85.66M | 85.23M | 85.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |